{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:32:28Z","timestamp":1761744748219,"version":"3.37.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Veterens Affairs Merit System","award":["2 I01 BX001981-05A1"],"award-info":[{"award-number":["2 I01 BX001981-05A1"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL73101-01A and R01 HL107910-01","R01-HL-088105"],"award-info":[{"award-number":["R01 HL73101-01A and R01 HL107910-01","R01-HL-088105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-17-IBS-201"],"award-info":[{"award-number":["1-17-IBS-201"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11906-018-0876-9","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T09:24:55Z","timestamp":1530869095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Potential Role of Antihypertensive Medications in Preventing Excessive Arterial Stiffening"],"prefix":"10.1007","volume":"20","author":[{"given":"Guanghong","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annayya R.","family":"Aroor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Martinez-Lemus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"876_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphys.2015.00231","volume":"6","author":"G Jia","year":"2015","unstructured":"Jia G, Aroor AR, DeMarco VG, Martinez-Lemus LA, Meininger GA, Sowers JR. Vascular stiffness in insulin resistance and obesity. Front Physiol. 2015;6:231.","journal-title":"Front Physiol"},{"key":"876_CR2","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/HYP.0000000000000033","volume":"66","author":"RR Townsend","year":"2015","unstructured":"\u2022 Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698\u2013722. This study recommended that carotid\u2013femoral PWV is an appropriate method to measure arterial stiffness.","journal-title":"Hypertension"},{"key":"876_CR3","doi-asserted-by":"publisher","first-page":"39S","DOI":"10.1016\/j.amjhyper.2004.08.019","volume":"17","author":"EL Schiffrin","year":"2004","unstructured":"Schiffrin EL. Vascular stiffening and arterial compliance. Implications for systolic blood pressure. Am J Hypertens. 2004;17:39S\u201348S.","journal-title":"Am J Hypertens"},{"key":"876_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.109.886655","volume":"121","author":"GF Mitchell","year":"2010","unstructured":"Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121:505\u201311.","journal-title":"Circulation"},{"key":"876_CR5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"876_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/hr.2014.109","volume":"37","author":"T Tomimatsu","year":"2014","unstructured":"Tomimatsu T, Fujime M, Kanayama T, Mimura K, Koyama S, Kanagawa T, et al. Abnormal pressure-wave reflection in pregnant women with chronic hypertension: association with maternal and fetal outcomes. Hypertens Res. 2014;37:989\u201392.","journal-title":"Hypertens Res"},{"key":"876_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/01.RES.50.5.671","volume":"50","author":"A Takeshita","year":"1982","unstructured":"Takeshita A, Imaizumi T, Ashihara T, Yamamoto K, Hoka S, Nakamura M. Limited maximal vasodilator capacity of forearm resistance vessels in normotensive young men with a familial predisposition to hypertension. Circ Res. 1982;50:671\u20137.","journal-title":"Circ Res"},{"key":"876_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/cvr\/cvy023","volume":"114","author":"RM Touyz","year":"2018","unstructured":"Touyz RM, Alves-Lopes R, Rios FJ, Camargo LL, Anagnostopoulou A, Arner A, et al. Vascular smooth muscle contraction in hypertension. Cardiovasc Res. 2018;114:529\u201339.","journal-title":"Cardiovasc Res"},{"key":"876_CR9","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/HYPERTENSIONAHA.113.01744","volume":"62","author":"RM Weisbrod","year":"2013","unstructured":"Weisbrod RM, Shiang T, Al Sayah L, Fry JL, Bajpai S, Reinhart-King CA, et al. Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension. 2013;62:1105\u201310.","journal-title":"Hypertension"},{"key":"876_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.05674","volume":"66","author":"VG DeMarco","year":"2015","unstructured":"DeMarco VG, Habibi J, Jia G, Aroor AR, Ramirez-Perez FI, Martinez-Lemus LA, et al. Low-dose mineralocorticoid receptor blockade prevents western diet-induced arterial stiffening in female mice. Hypertension. 2015;66:99\u2013107.","journal-title":"Hypertension"},{"key":"876_CR11","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fphys.2017.00456","volume":"8","author":"LA Martinez-Lemus","year":"2017","unstructured":"\u2022 Martinez-Lemus LA, Aroor AR, Ramirez-Perez FI, Jia G, Habibi J, DeMarco VG, et al. Amiloride improves endothelial function and reduces vascular stiffness in female mice fed a western diet. Front Physiol. 2017;8:456. This study indicated EnNaC mediates western diet-induced endothelial dysfunction and aretrial stiffness in female mice.","journal-title":"Front Physiol"},{"key":"876_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.metabol.2017.08.008","volume":"78","author":"G Jia","year":"2018","unstructured":"Jia G, Habibi J, Aroor AR, Hill MA, DeMarco VG, Lee LE, et al. Enhanced endothelium epithelial sodium channel signaling prompts left ventricular diastolic dysfunction in obese female mice. Metabolism. 2018;78:69\u201379.","journal-title":"Metabolism"},{"key":"876_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00424-013-1356-3","volume":"466","author":"K Kusche-Vihrog","year":"2014","unstructured":"\u2022 Kusche-Vihrog K, Jeggle P, Oberleithner H. The role of ENaC in vascular endothelium. Pflugers Arch. 2014;466:851\u20139. This study emphasized that EnNaC is an aldosterone-regulated plasma membrane protein of the vascular endothelium that contributes to endothelium stiffness and hypertension.","journal-title":"Pflugers Arch"},{"key":"876_CR14","doi-asserted-by":"publisher","first-page":"H811","DOI":"10.1152\/ajpheart.00764.2012","volume":"305","author":"Y Zeng","year":"2013","unstructured":"\u2022 Zeng Y, Waters M, Andrews A, Honarmandi P, Ebong EE, Rizzo V, et al. Fluid shear stress induces the clustering of heparan sulfate via mobility of glypican-1 in lipid rafts. Am J Physiol Heart Circ Physiol. 2013;305:H811\u201320. This study showed the role of changes in glycocalyx organization that underlie mechanisms of mechanotransduction.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"876_CR15","doi-asserted-by":"publisher","first-page":"H830","DOI":"10.1152\/ajpheart.00964.2015","volume":"310","author":"I Merdzo","year":"2016","unstructured":"Merdzo I, Rutkai I, Tokes T, Sure VN, Katakam PV, Busija DW. The mitochondrial function of the cerebral vasculature in insulin-resistant Zucker obese rats. Am J Physiol Heart Circ Physiol. 2016;310:H830\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"876_CR16","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1152\/physrev.00003.2017","volume":"97","author":"P Lacolley","year":"2017","unstructured":"Lacolley P, Regnault V, Segers P, Laurent S. Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease. Physiol Rev. 2017;97:1555\u2013617.","journal-title":"Physiol Rev"},{"key":"876_CR17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/HYPERTENSIONAHA.114.04737","volume":"65","author":"G Jia","year":"2015","unstructured":"Jia G, Habibi J, Bostick BP, Ma L, DeMarco VG, Aroor AR, et al. Uric acid promotes left ventricular diastolic dysfunction in mice fed a western diet. Hypertension. 2015;65:531\u20139.","journal-title":"Hypertension"},{"key":"876_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"key":"876_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/micc.12323","volume":"23","author":"MA Hill","year":"2016","unstructured":"Hill MA, Meininger GA. Small artery mechanobiology: roles of cellular and non-cellular elements. Microcirculation. 2016;23:611\u20133.","journal-title":"Microcirculation"},{"key":"876_CR20","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1113\/jphysiol.2013.264929","volume":"592","author":"Z Hong","year":"2014","unstructured":"Hong Z, Sun Z, Li M, Li Z, Bunyak F, Ersoy I, et al. Vasoactive agonists exert dynamic and coordinated effects on vascular smooth muscle cell elasticity, cytoskeletal remodelling and adhesion. J Physiol. 2014;592:1249\u201366.","journal-title":"J Physiol"},{"key":"876_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/cvr\/cvs239","volume":"96","author":"Z Hong","year":"2012","unstructured":"Hong Z, Sun Z, Li Z, Mesquitta WT, Trzeciakowski JP, Meininger GA. Coordination of fibronectin adhesion with contraction and relaxation in microvascular smooth muscle. Cardiovasc Res. 2012;96:73\u201380.","journal-title":"Cardiovasc Res"},{"key":"876_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.116.07418","volume":"68","author":"A Lother","year":"2016","unstructured":"Lother A, Hein L. Vascular mineralocorticoid receptors: linking risk factors, hypertension, and heart disease. Hypertension. 2016;68:6\u201310.","journal-title":"Hypertension"},{"key":"876_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1161\/HYPERTENSIONAHA.117.10437","volume":"71","author":"SK Kim","year":"2018","unstructured":"Kim SK, McCurley AT, DuPont JJ, Aronovitz M, Moss ME, Stillman IE, et al. Smooth muscle cell-mineralocorticoid receptor as a mediator of cardiovascular stiffness with aging. Hypertension. 2018;71:609\u201321.","journal-title":"Hypertension"},{"key":"876_CR24","doi-asserted-by":"publisher","first-page":"e0185319","DOI":"10.1371\/journal.pone.0185319","volume":"12","author":"A Tarjus","year":"2017","unstructured":"Tarjus A, Maase M, Jeggle P, Martinez-Martinez E, Fassot C, Loufrani L, et al. The endothelial alphaENaC contributes to vascular endothelial function in vivo. PLoS One. 2017;12:e0185319.","journal-title":"PLoS One"},{"key":"876_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1161\/CIRCRESAHA.115.308269","volume":"118","author":"G Jia","year":"2016","unstructured":"Jia G, Habibi J, Aroor AR, Martinez-Lemus LA, DeMarco VG, Ramirez-Perez FI, et al. Endothelial mineralocorticoid receptor mediates diet-induced aortic stiffness in females. Circ Res. 2016;118:935\u201343.","journal-title":"Circ Res"},{"key":"876_CR26","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1210\/en.2013-1256","volume":"154","author":"C Manrique","year":"2013","unstructured":"Manrique C, DeMarco VG, Aroor AR, Mugerfeld I, Garro M, Habibi J, et al. Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a western diet. Endocrinology. 2013;154:3632\u201342.","journal-title":"Endocrinology"},{"key":"876_CR27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fendo.2013.00161","volume":"4","author":"AR Aroor","year":"2013","unstructured":"Aroor AR, Demarco VG, Jia G, Sun Z, Nistala R, Meininger GA, et al. The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front Endocrinol (Lausanne). 2013;4:161.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"876_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL. Vascular actions of aldosterone. J Vasc Res. 2013;50:89\u201399.","journal-title":"J Vasc Res"},{"key":"876_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.113.01910","volume":"63","author":"JM Brown","year":"2014","unstructured":"Brown JM, Williams JS, Luther JM, Garg R, Garza AE, Pojoga LH, et al. Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone. Hypertension. 2014;63:273\u201380.","journal-title":"Hypertension"},{"key":"876_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/10641963.2015.1131285","volume":"38","author":"Q Liu","year":"2016","unstructured":"Liu Q, Han L, Du Q, Zhang M, Zhou S, Shen X. The association between oxidative stress, activator protein-1, inflammatory, total antioxidant status and artery stiffness and the efficacy of olmesartan in elderly patients with mild-to-moderate essential hypertension. Clin Exp Hypertens. 2016;38:365\u20139.","journal-title":"Clin Exp Hypertens"},{"key":"876_CR31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","volume":"71","author":"MJ Rossman","year":"2018","unstructured":"Rossman MJ, Santos-Parker JR, Steward CAC, Bispham NZ, Cuevas LM, Rosenberg HL, et al. Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension. 2018;71:1056\u201363.","journal-title":"Hypertension"},{"key":"876_CR32","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1210\/en.2006-1157","volume":"148","author":"Y Hirono","year":"2007","unstructured":"Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, et al. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system. Endocrinology. 2007;148:1688\u201396.","journal-title":"Endocrinology"},{"key":"876_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/HYPERTENSIONAHA.113.02129","volume":"64","author":"RD Spescha","year":"2014","unstructured":"Spescha RD, Glanzmann M, Simic B, Witassek F, Keller S, Akhmedov A, et al. Adaptor protein p66(Shc) mediates hypertension-associated, cyclic stretch-dependent, endothelial damage. Hypertension. 2014;64:347\u201353.","journal-title":"Hypertension"},{"key":"876_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-017-0531-9","volume":"16","author":"X Ren","year":"2017","unstructured":"Ren X, Ren L, Wei Q, Shao H, Chen L, Liu N. Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. Cardiovasc Diabetol. 2017;16:52.","journal-title":"Cardiovasc Diabetol"},{"key":"876_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1161\/ATVBAHA.115.306263","volume":"36","author":"N Xia","year":"2016","unstructured":"Xia N, Horke S, Habermeier A, Closs EI, Reifenberg G, Gericke A, et al. Uncoupling of endothelial nitric oxide synthase in perivascular adipose tissue of diet-induced obese mice. Arterioscler Thromb Vasc Biol. 2016;36:78\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"876_CR36","doi-asserted-by":"publisher","first-page":"e000885","DOI":"10.1161\/JAHA.112.000885","volume":"1","author":"G Thanassoulis","year":"2012","unstructured":"Thanassoulis G, Massaro JM, Corsini E, Rogers I, Schlett CL, Meigs JB, et al. Periaortic adipose tissue and aortic dimensions in the Framingham Heart Study. J Am Heart Assoc. 2012;1:e000885.","journal-title":"J Am Heart Assoc"},{"key":"876_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","volume":"36","author":"M Fasshauer","year":"2015","unstructured":"Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36:461\u201370.","journal-title":"Trends Pharmacol Sci"},{"key":"876_CR38","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1161\/ATVBAHA.114.303030","volume":"34","author":"A Omar","year":"2014","unstructured":"Omar A, Chatterjee TK, Tang Y, Hui DY, Weintraub NL. Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol. 2014;34:1631\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"876_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.tem.2015.04.003","volume":"26","author":"M Gil-Ortega","year":"2015","unstructured":"Gil-Ortega M, Somoza B, Huang Y, Gollasch M, Fernandez-Alfonso MS. Regional differences in perivascular adipose tissue impacting vascular homeostasis. Trends Endocrinol Metab. 2015;26:367\u201375.","journal-title":"Trends Endocrinol Metab"},{"key":"876_CR40","doi-asserted-by":"publisher","first-page":"R1198","DOI":"10.1152\/ajpregu.00262.2014","volume":"307","author":"G Jia","year":"2014","unstructured":"Jia G, Aroor AR, Martinez-Lemus LA, Sowers JR. Overnutrition, mTOR signaling, and cardiovascular diseases. Am J Physiol Regul Integr Comp Physiol. 2014;307:R1198\u2013206.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"876_CR41","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1172\/JCI41080","volume":"120","author":"MG Usher","year":"2010","unstructured":"Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schutz G, et al. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest. 2010;120:3350\u201364.","journal-title":"J Clin Invest"},{"key":"876_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fphys.2013.00314","volume":"4","author":"CJ Huang","year":"2013","unstructured":"Huang CJ, Webb HE, Zourdos MC, Acevedo EO. Cardiovascular reactivity, stress, and physical activity. Front Physiol. 2013;4:314.","journal-title":"Front Physiol"},{"key":"876_CR43","doi-asserted-by":"publisher","first-page":"H340","DOI":"10.1152\/ajpheart.00447.2016","volume":"312","author":"RE Harvey","year":"2017","unstructured":"Harvey RE, Barnes JN, Hart EC, Nicholson WT, Joyner MJ, Casey DP. Influence of sympathetic nerve activity on aortic hemodynamics and pulse wave velocity in women. Am J Physiol Heart Circ Physiol. 2017;312:H340\u20136.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"876_CR44","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1113\/JP271584","volume":"594","author":"VC Biancardi","year":"2016","unstructured":"Biancardi VC, Stern JE. Compromised blood-brain barrier permeability: novel mechanism by which circulating angiotensin II signals to sympathoexcitatory centres during hypertension. J Physiol. 2016;594:1591\u2013600.","journal-title":"J Physiol"},{"key":"876_CR45","doi-asserted-by":"publisher","first-page":"H190","DOI":"10.1152\/ajpheart.00622.2006","volume":"292","author":"KD Monahan","year":"2007","unstructured":"Monahan KD, Leuenberger UA, Ray CA. Aldosterone impairs baroreflex sensitivity in healthy adults. Am J Physiol Heart Circ Physiol. 2007;292:H190\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"876_CR46","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/HYPERTENSIONAHA.112.194787","volume":"60","author":"P Raheja","year":"2012","unstructured":"Raheja P, Price A, Wang Z, Arbique D, Adams-Huet B, Auchus RJ, et al. Spironolactone prevents chlorthalidone-induced sympathetic activation and insulin resistance in hypertensive patients. Hypertension. 2012;60:319\u201325.","journal-title":"Hypertension"},{"key":"876_CR47","first-page":"1462","volume":"28","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. The task force for the management of arterial hypertension of the European Society of H and the task force for the management of arterial hypertension of the European Society of C. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007;28:1462\u2013536.","journal-title":"Eur Heart J"},{"key":"876_CR48","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2337\/dc09-0149","volume":"32","author":"KM Madden","year":"2009","unstructured":"Madden KM, Lockhart C, Cuff D, Potter TF, Meneilly GS. Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care. 2009;32:1531\u20135.","journal-title":"Diabetes Care"},{"key":"876_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/HYPERTENSIONAHA.117.09026","volume":"70","author":"TJ Niiranen","year":"2017","unstructured":"Niiranen TJ, Lyass A, Larson MG, Hamburg NM, Benjamin EJ, Mitchell GF, et al. Prevalence, correlates, and prognosis of healthy vascular aging in a western community-dwelling cohort: the Framingham Heart Study. Hypertension. 2017;70:267\u201374.","journal-title":"Hypertension"},{"key":"876_CR50","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrcardio.2017.155","volume":"15","author":"ME Safar","year":"2018","unstructured":"Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018;15:97\u2013105.","journal-title":"Nat Rev Cardiol"},{"key":"876_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10557-010-6250-z","volume":"24","author":"DA Duprez","year":"2010","unstructured":"Duprez DA. Is vascular stiffness a target for therapy? Cardiovasc Drugs Ther. 2010;24:305\u201310.","journal-title":"Cardiovasc Drugs Ther"},{"key":"876_CR52","doi-asserted-by":"publisher","first-page":"621437","DOI":"10.1155\/2014\/621437","volume":"2014","author":"M Janic","year":"2014","unstructured":"Janic M, Lunder M, Sabovic M. Arterial stiffness and cardiovascular therapy. Biomed Res Int. 2014;2014:621437.","journal-title":"Biomed Res Int"},{"key":"876_CR53","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jacc.2003.07.039","volume":"43","author":"GM London","year":"2004","unstructured":"London GM, Asmar RG, O\u2019Rourke MF, Safar ME, Investigators RP. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril\/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"876_CR54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1161\/HYPERTENSIONAHA.106.085738","volume":"49","author":"GF Mitchell","year":"2007","unstructured":"Mitchell GF, Dunlap ME, Warnica W, Ducharme A, Arnold JM, Tardif JC, et al. Prevention of events with angiotensin-converting enzyme inhibition I. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension. 2007;49:1271\u20137.","journal-title":"Hypertension"},{"key":"876_CR55","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","volume":"359","author":"B Dahlof","year":"2002","unstructured":"Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995\u20131003.","journal-title":"Lancet"},{"key":"876_CR56","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","volume":"363","author":"S Julius","year":"2004","unstructured":"Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022\u201331.","journal-title":"Lancet"},{"key":"876_CR57","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/jch.12986","volume":"19","author":"T Kalizki","year":"2017","unstructured":"Kalizki T, Schmidt BMW, Raff U, Reinold A, Schwarz TK, Schneider MP, et al. Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension. J Clin Hypertens (Greenwich). 2017;19:669\u201376.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"876_CR58","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s40265-016-0642-8","volume":"76","author":"AC Cameron","year":"2016","unstructured":"Cameron AC, Lang NN, Touyz RM. Drug treatment of hypertension: focus on vascular health. Drugs. 2016;76:1529\u201350.","journal-title":"Drugs"},{"key":"876_CR59","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2169\/internalmedicine.54.3427","volume":"54","author":"T Shibata","year":"2015","unstructured":"Shibata T, Tsutsumi J, Hasegawa J, Sato N, Murashima E, Mori C, et al. Effects of add-on therapy consisting of a selective mineralocorticoid receptor blocker on arterial stiffness in patients with uncontrolled hypertension. Intern Med. 2015;54:1583\u20139.","journal-title":"Intern Med"},{"key":"876_CR60","doi-asserted-by":"publisher","first-page":"e006078","DOI":"10.1161\/JAHA.117.006078","volume":"6","author":"A Karras","year":"2017","unstructured":"Karras A, Boutouyrie P, Briet M, Bozec E, Haymann JP, Legendre C, et al. Reversal of arterial stiffness and maladaptative arterial remodeling after kidney transplantation. J Am Heart Assoc. 2017;6:e006078.","journal-title":"J Am Heart Assoc"},{"key":"876_CR61","doi-asserted-by":"publisher","first-page":"20862","DOI":"10.1038\/srep20862","volume":"6","author":"CW Liao","year":"2016","unstructured":"Liao CW, Lin LY, Hung CS, Lin YT, Chang YY, Wang SM, et al. Time course and factors predicting arterial stiffness reversal in patients with aldosterone-producing adenoma after adrenalectomy: prospective study of 102 patients. Sci Rep. 2016;6:20862.","journal-title":"Sci Rep"},{"key":"876_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/svn-2016-000045","volume":"2","author":"Y Chen","year":"2017","unstructured":"Chen Y, Shen F, Liu J, Yang GY. Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke. Stroke Vasc Neurol. 2017;2:65\u201372.","journal-title":"Stroke Vasc Neurol"},{"key":"876_CR63","doi-asserted-by":"publisher","first-page":"e41757","DOI":"10.1371\/journal.pone.0041757","volume":"7","author":"M Frimodt-Moller","year":"2012","unstructured":"Frimodt-Moller M, Kamper AL, Strandgaard S, Kreiner S, Nielsen AH. Beneficial effects on arterial stiffness and pulse-wave reflection of combined enalapril and candesartan in chronic kidney disease\u2014a randomized trial. PLoS One. 2012;7:e41757.","journal-title":"PLoS One"},{"key":"876_CR64","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MAJ.0b013e3181d658c4","volume":"339","author":"M Doi","year":"2010","unstructured":"Doi M, Miyoshi T, Hirohata S, Kamikawa S, Usui S, Kaji Y, et al. Combination therapy of calcium channel blocker and angiotensin II receptor blocker reduces augmentation index in hypertensive patients. Am J Med Sci. 2010;339:433\u20139.","journal-title":"Am J Med Sci"},{"key":"876_CR65","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/S0895-7061(02)02982-5","volume":"15","author":"A Mahmud","year":"2002","unstructured":"Mahmud A, Feely J. Effect of angiotensin ii receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens. 2002;15:1092\u20135.","journal-title":"Am J Hypertens"},{"key":"876_CR66","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/FJC.0b013e31817a8316","volume":"51","author":"JM Ferguson","year":"2008","unstructured":"Ferguson JM, Minas J, Siapantas S, Komesaroff PA, Sudhir K. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension. J Cardiovasc Pharmacol. 2008;51:590\u20135.","journal-title":"J Cardiovasc Pharmacol"},{"key":"876_CR67","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2125.2012.04342.x","volume":"75","author":"CH Manisty","year":"2013","unstructured":"Manisty CH, Hughes AD. Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index. Br J Clin Pharmacol. 2013;75:79\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"876_CR68","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(05)67573-3","volume":"366","author":"LH Lindholm","year":"2005","unstructured":"Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet. 2005;366:1545\u201353.","journal-title":"Lancet"},{"key":"876_CR69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.metabol.2017.06.006","volume":"74","author":"AR Aroor","year":"2017","unstructured":"Aroor AR, Jia G, Habibi J, Sun Z, Ramirez-Perez FI, Brady B, et al. Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice. Metabolism. 2017;74:32\u201340.","journal-title":"Metabolism"},{"key":"876_CR70","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/hy1101.095010","volume":"38","author":"JH Pratt","year":"2001","unstructured":"Pratt JH, Eckert GJ, Newman S, Ambrosius WT. Blood pressure responses to small doses of amiloride and spironolactone in normotensive subjects. Hypertension. 2001;38:1124\u20139.","journal-title":"Hypertension"},{"key":"876_CR71","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1021\/jm051134w","volume":"49","author":"AJ Hirsh","year":"2006","unstructured":"Hirsh AJ, Molino BF, Zhang J, Astakhova N, Geiss WB, Sargent BJ, et al. Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis. J Med Chem. 2006;49:4098\u2013115.","journal-title":"J Med Chem"},{"key":"876_CR72","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1124\/jpet.107.130443","volume":"325","author":"AJ Hirsh","year":"2008","unstructured":"Hirsh AJ, Zhang J, Zamurs A, Fleegle J, Thelin WR, Caldwell RA, et al. Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N\u2032-4-[4-(2,3-dihydroxypropoxy)phenyl] butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease. J Pharmacol Exp Ther. 2008;325:77\u201388.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-018-0876-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T16:58:04Z","timestamp":1589734684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-018-0876-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":72,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1007\/s11906-018-0876-9","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"type":"print","value":"1522-6417"},{"type":"electronic","value":"1534-3111"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"6 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"76"}}